SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Signet Laboratories, Inc. Announces License Agreement With Bayer Diagnostics For Urinary Trypsin Inhibitor Immunoassays To Further Research Inflammatory Disease